Maridebart Cafraglutide: A Physician’s Read on a Monthly GLP-1 Antibody-Peptide Conjugate

A GLP-1 agonist carried by a GIP receptor blocking antibody, dosed every 4 to 8 weeks. A short physician’s read on the design, the data and the open questions.